Previous Page  5 / 33 Next Page
Information
Show Menu
Previous Page 5 / 33 Next Page
Page Background

Page 33

Notes:

conferenceseries

.com

Volume 3, Issue 1 (Suppl)

Toxicol Open Access

ISSN: 2476-2067 TYOA, an open access journal

Toxicology Congress 2017

April 13-15, 2017

April 13-15, 2017 Dubai, UAE

8

th

World Congress on

Toxicology and Pharmacology

Baclofen systemic toxicity: Experimental histopathological and biochemical study

Sahar Y Issa

1

, Essam M Hafez

2

, Asmaa S El-Banna

1

, Safaa M Abdel Rahman

3

, Maha K AlMazroua

4

and

Mostafa Abo El-Hamd

2

1

Alexandria University Faculty of Medicine, Egypt

2

Minia University, Egypt

3

Central Laboratory, Egypt

4

Dammam Poison Control Center, KSA

T

he study was performed on 30 healthy adult male Albino rats divided into four groups with five rats in each control

group, and ten rats in either experimental groups (two experimental and two control groups). Five rats (negative control)

were kept in a quite non-stressful environment, provided with food ad libitum and free access to water. Normal saline (1

ml) was given orally as placebo in the positive control group (n=5). Experimental group III, Baclofen acute toxicity group

(10 rats): Each animal received a single dose of LD50 of Baclofen orally

by gavage. It equals 145 mg/kg b wt. The rats were observed for acute

toxicity manifestations as well as for LD50 deaths. Group IV, (Baclofen

dependent group 10 rats): Each animal received Baclofen (1/10

th

LD50)

in gradually increasing doses for one month. The levels of blood urea

nitrogen (BUN), creatinine kinase (CK), alanine aminotransferase

(ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP),

gamma-glutamyl transpeptidase (GGT), cardiac troponin I (CTnl),

prothrombin time (PT), in both Baclofen treated groups showed

significant elevation when compared to controls. There were brain, lung,

gastric, hepatic, and renal histopathological changes in Baclofen treated

rats whose severity varied between the two experimental groups.

Biography

Sahar Y Issa has completed her Doctorate degree in Clinical Toxicology & Forensic Medicine in 2008, from Faculty of Medicine, Alexandria University, Egypt and

is a Lecturer of Clinical Toxicology & Forensic Medicine in the same University. She is currently a Consultant Toxicologist, and the Medical Director, supervising

Emergency Toxicology, Molecular Toxicology, & Therapeutic Drug Monitoring units in Dammam Poison Control Center, MOH - Saudi Arabia. She has published

more than 25 papers in reputed journals and serving as an Editorial Board Member of repute.

sahar_issa71@yahoo.com

Sahar Y Issa et al., Toxicol Open Access 2017, 3:1 (Suppl)

http://dx.doi.org/10.4172/2476-2067.C1.002

Figure 1:

Renal tissue in different groups